Takata, Kazuyuki <br/><br/>
Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.  [electronic resource] 

 -  The European journal of neuroscience  Nov 2007 
 - 2458-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0953-816X 
<br/><br/><label>Standard No.: </label>10.1111/j.1460-9568.2007.05852.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--drug therapy<br/>Amyloid beta-Peptides--antagonists & inhibitors<br/>Animals<br/>Animals, Newborn<br/>Antibodies--immunology<br/>Brain--drug effects<br/>Cells, Cultured<br/>Coculture Techniques<br/>Cytokines--drug effects<br/>Down-Regulation--drug effects<br/>Encephalitis--chemically induced<br/>Gliosis--chemically induced<br/>Glycosylation<br/>Humans<br/>Injections, Intravenous<br/>Mice<br/>Mice, Transgenic<br/>Microglia--drug effects<br/>Phagocytosis--drug effects<br/>Polysaccharides--chemistry<br/>Rats<br/>Rats, Wistar<br/>Treatment Outcome